Business2 sources
New pancreatic cancer drug halts tumor growth in 90% of patients
- A new pancreatic cancer drug halted tumor growth in 90% of patients in a small-scale trial.
- The successful trial has raised hopes that the new approach could be extended to other types of the disease.
- The drug is hailed as the 'closest thing to a cure' and a 'biggest breakthrough in decades'.
- The trial results have generated massive hope for a new treatment option for pancreatic cancer.
- Further research and larger-scale trials are needed to confirm the drug's effectiveness and safety.
Articles (4)
Google News·
New drug combo shrinks tumors in most patients facing aggressive cancer type
Google News·
Cancer Pill Shows Tumor Shrinkage That's Unprecedented
Financial Times·
New pancreatic cancer drug halts tumour growth in 90% of patients
Google News·
New pancreatic cancer drug halts tumour growth in 90% of patients